China Development Industrial Bank (CDIB)
CDIB is a venture capital and investment banking company focused on funding high technology companies.
Business Model:
Revenue: $62M
Employees: 501-1,000
Rankings
Industries / Tags:
Detailed China Development Industrial Bank (CDIB) Information
Geographic Data
Address: No.125,Sec.5, Nanjing East Rd.
City: Taipei
State: taiwan (disputed)
Zip: 10504
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
CDIB pioneered venture capital and investment banking in Taiwan and today it remains the predominant leader in venture capital business in Taiwan with a market share of over 30%. Along with Taiwan&s;s industrial development, CDIB has built up a wealth of experience in high-tech investment while its investment overseas has extended to the US, Japan, Korea and S.E. Asia.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 12/2005 | Light Sciences Oncology | Series A | 32M |
| 6/2003 | Sandbridge Technologies | Series B | 19.5M |
| 6/2004 | Continuous Computing | Venture Round | 15M |
| 3/2001 | Vaultus | Series B | 0 |
| 6/2015 | Zentera Systems | Series A | 4.9M |
| 9/2015 | Kaixin Dai | Angel Round | 34M |
| 3/2001 | Calimetrics | Series C | 25M |
| 7/2001 | Nereus Pharmaceuticals | Series B | 23.6M |
| 9/2015 | WeDoctor | Series C | 0 |
| 7/2001 | Wintegra | Series B | 10M |
| 6/2001 | LocatioNet Systems | Venture Round | 2M |
| 10/2002 | HeyAnita | Series C | 7M |
| 7/2016 | Yilu Tong | Series A | 3M |
| 4/2004 | MontaVista Software | Venture Round | 7M |
| 10/2001 | Aderis Pharmaceuticals | Series D | 0 |
| 12/2004 | CipherMax | Series D | 29M |
| 6/2014 | Eden Biologics | Series B | 0 |
| 1/2003 | Iomai Corporation | Series C | 54M |
| 1/2004 | TargeGen | Series B | 30M |
| 12/2003 | Xanthus Pharmaceuticals | Series B | 0 |
| 6/2005 | Pixim | Venture Round | 0 |
| 12/2005 | Optimer Pharmaceuticals | Series D | 22.2M |
| 8/2021 | Elixiron Immunotherapeutics | Series A | 0 |
| 3/2002 | SiRF Technology | Private Equity Round | 0 |
| 10/2001 | Maxxan Systems | Series B | 20M |
| 12/2001 | R2 Technology | Venture Round | 0 |
| 5/2003 | Santarus | Series D | 51.4M |
| 10/2001 | GeneFormatics | Venture Round | 0 |
| 4/2002 | Magis Networks | Series B | 40M |
| 11/2003 | Zeevo | Series E | 0 |
| 9/2001 | Optimer Pharmaceuticals | Series B | 32M |
| 10/2001 | Altus Pharmaceuticals | Series B | 50.8M |
| 10/2001 | CipherMax | Series A | 0 |
| 9/2002 | CipherMax | Series B | 0 |
| 9/2001 | PTC Therapeutics | Series D | 0 |
| 4/2016 | Ant Group | Series B | 0 |
| 7/2003 | ZettaCom | Series C | 0 |
| 10/2001 | HeyAnita | Series B | - |
| 10/2001 | Pixim | Series C | 0 |
| 1/2002 | Myogen | Series D | 14M |
| 5/2000 | SiRF Technology | Private Equity Round | 24.7M |
| 5/2018 | Eden Biologics | Post-IPO Equity | 0 |
| 11/2003 | Entropic | Series B | 0 |
| 2/2016 | iCHEF | Series A | 0 |
| 4/2000 | Webex | Venture Round | 0 |
| 12/1999 | Trivnet | Venture Round | 12M |
| 3/2004 | TaiGen Biotechnology | Series B | 0 |
| 10/2005 | Light Sciences Oncology | Series A | 35M |
| 8/2013 | Apexigen | Series A | 20M |
| 4/2003 | Nanosys | Series B | 0 |
| 10/2000 | Wavesplitter | Venture Round | 51M |
| 4/2001 | Genteric | Series B | 22M |
| 2/2004 | Morphotek | Series C | 26M |
| 9/1999 | Wavesplitter | Venture Round | 21M |
| 4/2003 | Pixim | Series D | 22M |
| 10/2003 | CipherMax | Series C | 20M |
| 8/2003 | Cavium | Series C | 18M |
| 10/2016 | Viscovery | Venture Round | 0 |
| 1/2002 | Medinox | Venture Round | 0 |
| 1/2001 | Acorda Therapeutics | Series A | 0 |
| 8/2021 | Elixiron Immunotherapeutics | Series A | 0 |
| 5/2018 | Eden Biologics | Post-IPO Equity | 0 |
| 10/2016 | Viscovery | Venture Round | 0 |
| 7/2016 | Yilu Tong | Series A | 0 |
| 4/2016 | Ant Group | Series B | 0 |
| 2/2016 | iCHEF | Series A | 0 |
| 9/2015 | Kaixin Dai | Angel Round | 0 |
| 9/2015 | WeDoctor | Series C | 0 |
| 6/2015 | Zentera Systems | Series A | 0 |
| 6/2014 | Eden Biologics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
